Evidence map›Paper›PMID 38675589›Full record

ArticleMolecules (Basel, Switzerland)2024

The Increased Dissolution and Oral Absorption of Itraconazole by Nanocrystals with an Endogenous Small-Molecule Surfactant as a Stabilizer.

Sheng Chang, Qiang Yang, Jiahuan Liu, Li Yin, Jihong Han, Lanlan Zong, Xiaohui Pu

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Sheng ChangCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.
Qiang YangState Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China.
Jiahuan LiuCollege of Pharmacy, Jilin Medical University, Jilin 132013, China.
Li YinState Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China.
Jihong HanSchool of Pharmacy and Bioengineering, Keele University, Kiel ST5 5BG, UK.
Lanlan ZongState Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China.
Xiaohui PuState Key Laboratory of Antiviral Drugs, School of Pharmacy, Henan University, Kaifeng 475004, China.ORCID 0000-0002-9359-9651

Funding

Natural Science Foundation of Jilin Provincial 20210101033JC
6 · The paper itself

Abstract

The aim of this study was to develop cholic-acid-stabilized itraconazole nanosuspensions (ITZ-Nanos) with the objective of enhancing drug dissolution and oral absorption. A laboratory-scale microprecipitation-high-pressure homogenization method was employed for the preparation of the ITZ-Nanos, while dynamic light scattering, transmission electron microscope analysis, X-ray diffraction, differential scanning calorimetry, and high-performance liquid chromatography analysis were utilized to evaluate their physicochemical properties. The absorption and bioavailability of the ITZ-Nanos were assessed using Caco-2 cells and rats, with Sporanox

Indexed as

ItraconazoleNanoparticlesSolubilitySurface-Active AgentsAdministration, OralAnimalsBiological AvailabilityCaco-2 CellsCalorimetry, Differential ScanningCholic AcidHumansMaleParticle SizeRatsX-Ray DiffractionCholic AcidItraconazoleSurface-Active Agentsbioavailabilitycholic acidin vivo pharmacokineticsitraconazolenanocrystalssupersaturation dissolution

Identifiers

PMID38675589
PMCPMC11052100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.